Rvl Pharmaceuticals Plc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2023, Rvl Pharmaceuticals Plc's inventory turnover ratio sequentially decreased to 11.28 in the second quarter 2023, otherwise the ratio remained above the average, as RVLP's markets remain strong.Rvl Pharmaceuticals Plc's average inventory processing period in the Jun 30 2023 quarter, has increased to 32 days, from 20 days, in the Mar 31 2023 quarter.

Within Healthcare sector 31 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2023 compared to previous quarter at no. 238.

RVLP Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Rvl Pharmaceuticals Plc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

RVLP Inventory Turnover Ratio	(Jun 30 2023) II. Quarter	(Mar 31 2023) I. Quarter	(Dec 31 2022) IV. Quarter	(Sep 30 2022) III. Quarter	(Jun 30 2022) II. Quarter
Y / Y Inventory Growth	156.82 %	-74.58 %	-6.44 %	-24.64 %	-48.24 %
Y / Y Cost of Sales Growth	-55.1 %	7.23 %	136.38 %	120.14 %	214.1 %
Inventory Turnover Ratio (TTM)	11.28	17.91	13.65	11.3	8.72
RVLP's Total Ranking	# 238	# 238	# 294	# 580	# 580
Average inventory processing period	32	20	27	32	42
Seq. Inventory Growth	536.62 %	-72.83 %	26.25 %	17.61 %	-36.99 %
Seq. Cost of Sales Growth	-56.5 %	-10.2 %	1.39 %	13.38 %	3.87 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 10
Healthcare Sector	# 32
Overall Market	# 238

Inventory Turnover Ratio Statistics
High	Average	Low
17.91	3.88	-4.07
(Mar 31 2023)		(Sep 30 2020)

RVLP Company Profile >> Back to RVLP Efficiency Comparisons >> Compare RVLP Inventory Turnover Ratio to its Competitors

Financial Statements
Rvl Pharmaceuticals Plc's Inventories	$ 1 Millions	Visit RVLP's Balance sheet
Rvl Pharmaceuticals Plc's Cost of Revenues TTM	$ 8 Millions	Visit RVLP's Income Statement
What are RVLP's Sales?		Visit RVLP's Sales by Segment

Other Inventory Turnover Ratios
Rvl Pharmaceuticals Plc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
RVLP's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for RVLP's Competitors
Inventory Turnover Ratio for RVLP's Suppliers
Inventory Turnover Ratio for RVLP's Customers

You may also want to know
RVLP's Sales Growth Rates	RVLP's Pe Price to earnings ratio	RVLP's Receivables Turnover Ratio	RVLP's Stock Quote
RVLP's Net Income Growth Rates	RVLP's Ps Price to Sales ratio	RVLP's Sales per Employee	RVLP's Asset Turnover Ratio
RVLP's Net Margin	RVLP's Pb Price to Book ratio	RVLP's Financial Strength Ratios	RVLP's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2023, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2023	Inventories at quarter ending Jun 30 2023
Vanda Pharmaceuticals Inc	16.77	$ 20.831 Millions	$ 1 Millions
Viemed Healthcare Inc	16.76	$ 61.477 Millions	$ 4 Millions
Biocept Inc	16.02	$ 15.660 Millions	$ 1 Millions
Novavax inc	15.98	$ 706.221 Millions	$ 44 Millions
Teladoc Health Inc	15.45	$ 755.139 Millions	$ 49 Millions
Invitae Corporation	15.40	$ 385.716 Millions	$ 25 Millions
Aspira Women s Health inc	13.32	$ 3.895 Millions	$ 0 Millions
Natera Inc	13.31	$ 529.903 Millions	$ 40 Millions
Option Care Health Inc	13.17	$ 3,204.135 Millions	$ 243 Millions
23andme Holding Co	13.04	$ 155.970 Millions	$ 12 Millions
Eton Pharmaceuticals Inc	12.97	$ 7.428 Millions	$ 1 Millions
Wearable Health Solutions, Inc.	12.96	$ 0.477 Millions	$ 0 Millions
Lantheus Holdings Inc	12.92	$ 530.615 Millions	$ 41 Millions
Precipio inc	12.72	$ 7.802 Millions	$ 1 Millions
Rockwell Medical inc	12.22	$ 67.973 Millions	$ 6 Millions
Qhslab Inc	11.70	$ 0.620 Millions	$ 0 Millions
Rvl Pharmaceuticals Plc	11.28	$ 8.384 Millions	$ 1 Millions
Sotera Health Company	10.95	$ 446.648 Millions	$ 41 Millions
Agile Therapeutics Inc	10.71	$ 21.081 Millions	$ 2 Millions
Myriad Genetics Inc	10.54	$ 221.300 Millions	$ 21 Millions
Sunlink Health Systems Inc	10.32	$ 18.571 Millions	$ 2 Millions
Infusystem Holdings Inc	10.26	$ 53.929 Millions	$ 5 Millions
Puma Biotechnology Inc	10.12	$ 54.406 Millions	$ 5 Millions
Genedx Holdings Corp	10.00	$ 204.264 Millions	$ 20 Millions
Cryo cell International Inc	9.80	$ 8.698 Millions	$ 1 Millions
Semler Scientific inc	9.77	$ 4.807 Millions	$ 0 Millions
Irhythm Holdings Inc	9.24	$ 139.619 Millions	$ 15 Millions
Dermtech Inc	9.13	$ 13.865 Millions	$ 2 Millions
Prophase Labs Inc	8.93	$ 37.550 Millions	$ 4 Millions
Bionexus Gene Lab Corp	8.67	$ 8.968 Millions	$ 1 Millions

Date modified: 2026-08-29T17:44:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.